September 01, 2015
A Virginia federal jury cleared drugmaker Eli Lilly & Co. on Tuesday of allegations it had negligently downplayed the risks of Cymbalta withdrawal in its labeling, shooting down the last claims of a trimmed-down suit from two women who claimed they suffered severe withdrawal symptoms.
August 28, 2015
A Virginia federal judge on Friday found that two women suing Eli Lilly and Co. for allegedly misrepresenting the withdrawal risks of its antidepressant drug Cymbalta had failed to present enough jury evidence to support their fraud claims, tossing them from court but keeping alive a negligence allegation.
August 24, 2015
Eli Lilly and Co. downplayed the withdrawal risk of its antidepressant drug Cymbalta to the point of fraud, a pair of women told a Virginia federal jury Monday, saying the company portrayed their symptoms as rare when almost half of the patients experienced similar withdrawal.